1 / 8

Oral Vaccine for Human Market Size & Growth Outlook 2024-2030

Oral vaccine for humans is a type of vaccine that is taken by mouth, often in the form of a liquid or a tablet. Its major goal is to elicit an immunological response in order to defend against specific diseases. Individuals seeking preventative healthcare, particularly those prone to infectious diseases, are among the end consumers of oral vaccinations.

tarusha
Télécharger la présentation

Oral Vaccine for Human Market Size & Growth Outlook 2024-2030

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Oral Vaccine for HumanMarket Research Report to Witness Huge Growth by 2023-2029 Powered by HTF Market Intelligence Consulting Pvt. Ltd.

  2. Market Definition & Scope Oral vaccines for humans are a fascinating aspect of medical science. These vaccines are designed to be administered through the mouth, typically in the form of a liquid or a dissolvable tablet. They leverage the body's mucosal immune system, which is present in the oral and respiratory mucosa, to stimulate an immune response against specific pathogens. Reports powered by HTF Market Intelligence Consulting Pvt. Ltd.

  3. Market Type • Inactivated Vaccines • Live Attenuated Vaccines • Viral Vector Vaccines • Others Powered by HTF Market Intelligence Consulting Pvt. Ltd.

  4. Market Application • General Public • Healthcare Professionals • Public Health Organisations • Others Powered by HTF Market Intelligence Consulting Pvt. Ltd.

  5. Key Players • Some of the key players profiled in the study are - • Pfizer (United States) • Moderna (United States) • Johnson & Johnson (United States) • Sinovac (China) • Bharat Biotech (India) • Sinopharm (China) • Novavax (United States) • Covovax (Serum Institute of India) (India) • CanSino Biologics (China) • Sanofi Pasteur (France) • Merck & Co. (United States) • GlaxoSmithKline (GSK) (United Kingdom) • Biological E (India) Powered by HTF Market Intelligence Consulting Pvt. Ltd.

  6. Regions • If opting for the Global Oral Vaccine for Human marketthen the below country analysis would be included: • North America (the USA, Canada, and Mexico) • Europe (Germany, France, the United Kingdom, Netherlands, Italy, Nordic Nations, Spain, Switzerland, and the Rest of Europe) • Asia-Pacific (China, Japan, Australia, New Zealand, South Korea, India, Southeast Asia, and the Rest of APAC) • South America (Brazil, Argentina, Chile, Colombia, the Rest of the countries, etc.) • The Middle East and Africa (Saudi Arabia, United Arab Emirates, Israel, Egypt, Turkey, Nigeria, South Africa, Rest of MEA) Powered by HTF Market Intelligence Consulting Pvt. Ltd.

  7. Sample Report Oral vaccine for humans is a type of vaccine that is taken by mouth, often in the form of a liquid or a tablet. Its major goal is to elicit an immunological response in order to defend against specific diseases. Individuals seeking preventative healthcare, particularly those prone to infectious diseases, are among the end consumers of oral vaccinations.  Get free access to sample report @ https://www.htfmarketintelligence.com/sample-report/global-oral-vaccine-for-human-market Powered by HTF Market Intelligence Consulting Pvt. Ltd.

  8. Contact Us Contact Us :Craig Francis (PR & Marketing Manager)HTF Market Intelligence Consulting Private LimitedPhone: +1 434 322 0091sales@htfmarketintelligence.comConnect with us atLinkedIn | Facebook | Twitter Powered by HTF Market Intelligence Consulting Pvt. Ltd.

More Related